|
CA9
Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia. Forms oligomers linked by disulfide bonds. By hypoxia. Expressed primarily in carcinoma cells lines. Expression is restricted to very few normal tissues and the most abundant expression is found in the epithelial cells of gastric mucosa. Inhibited by coumarins, saccharin, sulfonamide derivatives such as acetazolamide (AZA) and Foscarnet (phosphonoformate trisodium salt). Belongs to the alpha-carbonic anhydrase family. Note: This description may include information from UniProtKB.
|
| Protein type: EC 4.2.1.1; Lyase; Membrane protein, integral; Energy Metabolism - nitrogen |
|
Cellular Component: microvillus membrane; nucleolus; plasma membrane; integral to membrane
|
|
Molecular Function: carbonate dehydratase activity; zinc ion binding
|
|
Biological Process: secretion; bicarbonate transport; cellular response to stress; morphogenesis of an epithelium; one-carbon compound metabolic process
|
|
Reference #:
Q16790 (UniProtKB)
|
| Alt. Names/Synonyms: CA-IX; CA9; CAH9; CAIX; Carbonate dehydratase IX; Carbonic anhydrase 9; Carbonic anhydrase IX; carbonic dehydratase; G250; Membrane antigen MN; MN; P54/58N; pMW1; RCC-associated antigen G250; RCC-associated protein G250; Renal cell carcinoma-associated antigen G250 |
| Gene Symbols: CA9 |
|
Molecular weight: 49,698 Da
|
|
Basal Isoelectric point: 4.64
Predict pI for various phosphorylation states
|
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology®
|